Research Overview
The peptide behind the capsule
Why an oral format is studied at all
Peptides are generally poor oral candidates because gastric acid and proteases degrade them and because absorption across the intestinal epithelium is limited by size and polarity. BPC-157 is unusual in that a portion of the published work reports stability in gastric juice, which is what motivates oral-format experiments. Whether meaningful systemic exposure follows remains an open question, and route comparisons are exactly the kind of study this format supports.
What the arginate salt changes
- The peptide sequence, formula and molecular mass are identical to the acetate or free-peptide material.
- The counter-ion affects hygroscopicity, dissolution rate and the residual salt reported on analysis.
- Studies comparing salt forms typically hold the peptide mass constant and track dissolution and stability rather than sequence-level differences.
Local versus systemic exposure
Because an orally presented peptide meets the gastrointestinal lumen first, investigators distinguish between local mucosal exposure and systemic appearance. Designs that address this normally include a parenteral reference arm, plasma sampling and, where possible, tissue-level measurement rather than inferring systemic effect from an oral readout alone.
